Niagen Bioscience (NAGE) FCF Margin Growth (3y) (2016 - 2026)
Niagen Bioscience (NAGE) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Niagen Bioscience |
280.11 Mn |
213.56 Mn |
19.98 Mn |
-1,596.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-1,596.00 |
| Dec 31, 2025 |
409.00 |
| Sep 30, 2025 |
3,311.00 |
| Jun 30, 2025 |
2,689.00 |
| Mar 31, 2025 |
6,761.00 |
| Dec 31, 2024 |
5,708.00 |
| Sep 30, 2024 |
4,826.00 |
| Jun 30, 2024 |
4,489.00 |
| Mar 31, 2024 |
3,827.00 |
| Dec 31, 2023 |
457.00 |
| Sep 30, 2023 |
2,873.00 |
| Jun 30, 2023 |
2,567.00 |
| Mar 31, 2023 |
4,827.00 |
| Dec 31, 2022 |
442.00 |
| Sep 30, 2022 |
4,344.00 |
| Jun 30, 2022 |
5,847.00 |
| Mar 31, 2022 |
-914.00 |
| Dec 31, 2021 |
2,890.00 |
| Sep 30, 2021 |
3,017.00 |
| Jun 30, 2021 |
5,208.00 |
